(Q84284316)
Statements
Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial (English)
Michael E Weinblatt
Clifton O Bingham
Alan M Mendelsohn
Lilianne Kim
Michael Mack
Jiandong Lu
Daniel Baker